Article Sidebar

PDF (Tiếng Việt)
Published: 2022-02-22
Abstract Views: 391
Views PDF (Tiếng Việt): 358
DOI: https://doi.org/10.52852/tcncyh.v150i2.728
Issue
Vol. 150 No. 2 (2022)
Section
Các bài báo
How to Cite
Nhi, P. T. U. ., Thường, N. V., Hào, N. T., Vũ, H. A., & Trâm, D. B. (2022). Association between single nucleotide polymorphisms IL-17F RS763780, IL-17RA RS4819554 AND HLA-CW6 and psoriasis vulgaris in Vietnam. Journal of Medical Research, 150(2), 1-13. https://doi.org/10.52852/tcncyh.v150i2.728

Association between single nucleotide polymorphisms IL-17F RS763780, IL-17RA RS4819554 AND HLA-CW6 and psoriasis vulgaris in Vietnam

Pham Thi Uyen Nhi, Nguyen Van Thuong, Nguyen Trong Hao, Hoang Anh Vu, Duong Bich Tram

Main Article Content

Abstract

Psoriasis is a chronic recurrent inflammatory disease where genetic factors contribute 3% of the disease's pathogenesis; as such, the identification of biological markers is an important role in the prediction of treatment response and prognosis. This study determines basic characteristics in Vietnamese psoriasis vulgaris patients, prevalence and genotype of IL-17F RS763780, IL17RA rs4819554, and HLA-Cw6.  Blood test was performed on 121 samples, then DNA and genotype achieved by CLC Main Workbench software. Mean severity is 20,31 ± 12,70 and PASI is 14,88 ± 7,59. Genotype distribution is different in every position. Gene IL-17F rs763780 has the highest AA in psoriasis patients with 58.7%, GA takes 38.0%. Gene IL-17RA rs4819554 has 53.7% GA and 27.3%AA. 35.04% patients are HLA-Cw6 negative and 64.96% are positive. Patients with positive HLA-Cw6 have 77.63% heterozygous, and 22.37% homozygous. There is no correlation among HLA-Cw6, SNP IL-17F RS763780 and IL17RA rs4819554. However, there is the correlation between IL-17F RS763780 and the severity of psoriasis.

Article Details

Keywords

Single-nucleotide polymorphism, IL17RA, rs4819554, RS763780, HLA-Cw6, psoriasis vulgaris

References

1. Foundation NP. Published 2015.
2. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol. Sep 1999; 41(3 Pt 1): 401-407. doi: 10.1016/s0190-9622(99)70112-x.
3. International Human Genome Sequencing C. Finishing the euchromatic sequence of the human genome. Nature. Oct 21 2004;431(7011):931-945. doi: 10.1038/nature03001.
4. Osmola-Mankowska A, Teresiak-Mikolajczak E, Skrzypczak-Zielinska M, Adamski Z. Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future. Postepy Dermatol Alergol. Aug 2018;35(4):331-337. doi: 10.5114/ada.2018.77661.
5. Batalla A, Coto E, Gomez J, et al. IL17RA gene variants and anti-TNF response among psoriasis patients. Pharmacogenomics J. Jan 2018;18(1):76-80. doi: 10.1038/tpj.2016.70.
6. Batalla A, Coto E, Gonzalez-Lara L, et al. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort. J Dermatol Sci. Nov 2015;80(2):111-115. doi: 10.1016/j.jdermsci.2015.06.011.
7. Prieto-Perez R, Solano-Lopez G, Cabaleiro T, et al. The polymorphism rs763780 in the IL-17F gene is associated with response to biological drugs in patients with psoriasis. Pharmacogenomics. 2015; 16(15):1723-1731. doi: 10.2217/pgs.15.107.
8. Kim SY, Hur MS, Choi BG, et al. A preliminary study of new single polymorphisms in the T helper type 17 pathway for psoriasis in the Korean population. Clin Exp Immunol. Feb 2017;187(2):251-258. doi: 10.1111/cei.12888.
9. Zhang C, Zhu KJ, Liu H, et al. The TNFAIP3 polymorphism rs610604 both associates with the risk of psoriasis vulgaris and affects the clinical severity. Clin Exp Dermatol. Jun 2015;40(4):426-430. doi: 10.1111/ced.12536.
10. Võ Quang Đỉnh. Khảo sát yếu tố thuận lợi, lâm sàng và một số khác biệt lâm sàng giữa khởi phát sớm & muộn ở bệnh nhân vảy nến nội trú. Luận văn Thạc sĩ Y học. 2021.
11. Wang WJ, Yin XY, Zuo XB, et al. Gene-gene interactions in IL23/Th17 pathway contribute to psoriasis susceptibility in Chinese Han population. J Eur Acad Dermatol Venereol. Sep 2013;27(9):1156-1162. doi: 10.1111/j.1468-3083.2012.04683.x.
12. Enerback C, Martinsson T, Inerot A, et al. Evidence that HLA-Cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP). Acta Derm Venereol. Jul 1997; 77(4):273-276. doi: 10.2340/0001555577273276.
13. Gonzaga HF, Torres EA, Alchorne MM, Gerbase-Delima M. Both psoriasis and benign migratory glossitis are associated with HLA-Cw6. Br J Dermatol. Sep 1996; 135(3):368-370. https://www.ncbi.nlm.nih.gov/pubmed/8949427.
14. Johnston A, Guzman AM, Swindell WR, Wang F, Kang S, Gudjonsson JE. Early tissue responses in psoriasis to the antitumour necrosis factor-alpha biologic etanercept suggest reduced interleukin-17 receptor expression and signalling. Br J Dermatol. Jul 2014;171(1):97-107. doi: 10.1111/bjd.12937.
15. Wong LY, Hatfield JK, Brown MA. Ikaros sets the potential for Th17 lineage gene expression through effects on chromatin state in early T cell development. J Biol Chem. Dec 6 2013;288(49):35170-35179. doi: 10.1074/jbc.M113.481440.